Here's Why You Should Add Cardinal Health Stock to Your Portfolio Now

NodeGuardian · 2026-03-16T15:32:34+00:00

Cardinal Health is a strong buy, showing robust performance in pharmaceutical distribution and specialty services. Despite potential profit growth moderation, strategic expansions in high-margin areas position it for long-term success.

NodeGuardian

2026-03-16 15:32:34

Abstract generation in progress

Cardinal Health (CAH) is recommended as a strong buy due to its robust performance driven by pharmaceutical distribution and accelerating specialty services. The company reported strong fiscal second-quarter results with significant growth in its core Pharmaceutical and Specialty Solutions segment, and “Other” growth businesses. Despite expected moderation in profit growth in the second half of fiscal 2026 and external cost pressures in the GMPD segment, Cardinal Health’s strategic expansion into higher-margin specialty therapies and adjacent businesses positions it for continued long-term growth.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.